Published in J Clin Microbiol on September 12, 2012
Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother (2013) 2.73
Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob Agents Chemother (2012) 2.59
Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int (2014) 2.34
Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli. J Clin Microbiol (2013) 2.09
CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp. J Clin Microbiol (2014) 1.62
Evaluation of the Carba NP test for carbapenemase detection. Antimicrob Agents Chemother (2014) 1.54
The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods. PLoS One (2015) 1.31
Comparative evaluation of two chromogenic tests for rapid detection of carbapenemase in Enterobacteriaceae and in Pseudomonas aeruginosa isolates. J Clin Microbiol (2014) 1.13
Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the Verigene Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay. J Clin Microbiol (2015) 1.12
Matrix-assisted laser desorption ionization-time of flight mass spectrometry meropenem hydrolysis assay with NH4HCO3, a reliable tool for direct detection of carbapenemase activity. J Clin Microbiol (2015) 1.07
Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods. Clin Microbiol Rev (2016) 1.05
Rapidec Carba NP Test for Rapid Detection of Carbapenemase Producers. J Clin Microbiol (2015) 1.03
Evaluation of five chromogenic agar media and the Rosco Rapid Carb screen kit for detection and confirmation of carbapenemase production in Gram-negative bacilli. J Clin Microbiol (2014) 1.02
Further proofs of concept for the Carba NP test. Antimicrob Agents Chemother (2014) 1.02
Reply to "further proofs of concept for the Carba NP test". Antimicrob Agents Chemother (2014) 0.98
Rapid identification of carbapenemase-producing Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii using a modified Carba NP test. New Microbes New Infect (2015) 0.95
Dissemination of Carbapenemase-Producing Enterobacteriaceae and Pseudomonas aeruginosa in Romania. Antimicrob Agents Chemother (2015) 0.94
A convenient method to screen for carbapenemase-producing Pseudomonas aeruginosa. J Clin Microbiol (2013) 0.85
Comparative Study of a Novel Biochemical Assay, the Rapidec Carba NP Test, for Detecting Carbapenemase-Producing Enterobacteriaceae. J Clin Microbiol (2015) 0.83
The Soil Microbiota Harbors a Diversity of Carbapenem-Hydrolyzing β-Lactamases of Potential Clinical Relevance. Antimicrob Agents Chemother (2015) 0.81
A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations. J Clin Diagn Res (2016) 0.80
Evaluation of several phenotypic methods for the detection of carbapenemase-producing Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (2015) 0.78
Evaluation of phenotypic detection methods for metallo-β-lactamases (MBLs) in clinical isolates of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (2014) 0.78
Bloodstream infections caused by Pseudomonas spp.: how to detect carbapenemase producers directly from blood cultures. J Clin Microbiol (2014) 0.76
Rapid time to results and high sensitivity of the CarbaNP test on early cultures. J Clin Microbiol (2014) 0.75
Characterization of Pseudomonas aeruginosa with discrepant carbapenem susceptibility profile. Ann Clin Microbiol Antimicrob (2016) 0.75
First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis. J Clin Microbiol (2015) 0.75
In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa. BMC Infect Dis (2016) 0.75
Cilastatin does not affect Carba NP test performance for detection of carbapenemase production in Enterobacteriaceae. Wien Klin Wochenschr (2016) 0.75
Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis (2012) 5.81
Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect (2012) 3.58
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect (2007) 3.49
Emergence of NDM-1 metallo-β-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob Agents Chemother (2011) 2.25
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 1.87
A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamase GES-2 in South Africa. J Antimicrob Chemother (2002) 1.76
Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol (2008) 1.74
A simple test for the detection of KPC and metallo-β-lactamase carbapenemase-producing Pseudomonas aeruginosa isolates with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect (2011) 1.57
Sensitive and specific modified Hodge test for KPC and metallo-beta- lactamase detection in Pseudomonas aeruginosa by use of a novel indicator strain, Klebsiella pneumoniae ATCC 700603. J Clin Microbiol (2011) 1.43
Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands. Antimicrob Agents Chemother (2010) 1.38
Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species. Expert Opin Investig Drugs (2008) 1.36
Rapid characterization of beta-lactamases by multiplex PCR. Methods Mol Biol (2010) 1.28
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases. Antimicrob Agents Chemother (2010) 1.17
A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase. J Antimicrob Chemother (2006) 1.14
Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis (2011) 13.18
Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev (2005) 12.07
Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother (2004) 7.96
Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene. Antimicrob Agents Chemother (2008) 7.06
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis (2013) 6.60
CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother (2006) 6.58
Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis (2011) 6.44
Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet (2006) 6.32
Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis (2008) 6.21
Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis (2012) 5.81
Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother (2005) 4.87
Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med (2012) 4.77
Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother (2005) 4.65
OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother (2012) 4.63
Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother (2004) 4.46
Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother (2009) 4.33
Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis (2010) 4.25
Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother (2010) 4.23
Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother (2011) 4.16
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother (2005) 4.15
The emerging NDM carbapenemases. Trends Microbiol (2011) 4.08
Comparative analysis of Acinetobacters: three genomes for three lifestyles. PLoS One (2008) 3.94
Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase gene. Antimicrob Agents Chemother (2003) 3.94
Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. J Antimicrob Chemother (2002) 3.91
How to detect NDM-1 producers. J Clin Microbiol (2010) 3.84
Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother (2005) 3.77
Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol (2003) 3.74
Carbapenemases: molecular diversity and clinical consequences. Future Microbiol (2007) 3.67
OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother (2005) 3.63
Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother (2007) 3.61
Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2005) 3.41
Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother (2005) 3.25
In vitro analysis of ISEcp1B-mediated mobilization of naturally occurring beta-lactamase gene blaCTX-M of Kluyvera ascorbata. Antimicrob Agents Chemother (2006) 3.21
Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob Agents Chemother (2003) 3.19
Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother (2005) 3.18
Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother (2010) 3.15
Chromosome-encoded Ambler class A beta-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum beta-lactamases. Antimicrob Agents Chemother (2002) 3.12
Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Chemother (2011) 3.01
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother (2008) 2.97
Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory. J Clin Microbiol (2005) 2.89
Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother (2008) 2.88
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother (2009) 2.85
qnr Gene nomenclature. Antimicrob Agents Chemother (2008) 2.81
Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother (2011) 2.76
Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother (2010) 2.70
Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol (2011) 2.65
ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli. Antimicrob Agents Chemother (2005) 2.65
Molecular characterization of a novel class 1 integron containing bla(GES-1) and a fused product of aac3-Ib/aac6'-Ib' gene cassettes in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2002) 2.65
Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother (2010) 2.64
Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents (2007) 2.61
Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob Agents Chemother (2012) 2.59
Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis (2010) 2.58
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother (2007) 2.50
Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland. J Antimicrob Chemother (2002) 2.49
Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother (2003) 2.47
NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother (2010) 2.45
NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother (2011) 2.40
Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother (2011) 2.38
Chromosome-encoded ambler class D beta-lactamase of Shewanella oneidensis as a progenitor of carbapenem-hydrolyzing oxacillinase. Antimicrob Agents Chemother (2004) 2.37
A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J Antimicrob Chemother (2004) 2.32
Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 2.30
Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria. Antimicrob Agents Chemother (2005) 2.28
Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother (2006) 2.24
Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J Clin Microbiol (2011) 2.22
Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-pectrum beta-lactamase in Pseudomonas aeruginosa in Thailand. Clin Infect Dis (2002) 2.22
Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis (2010) 2.18
Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants. J Antimicrob Chemother (2005) 2.17
Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing. Antimicrob Agents Chemother (2011) 2.13
Diversity of genetic environment of bla(CTX-M) genes. FEMS Microbiol Lett (2004) 2.11
Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of beta-lactam resistance genes. J Bacteriol (2006) 2.09